Topical corticosteroids
| Drug monograph · NCLEX study reference | |
| Therapeutic class | Anti-inflammatory (skin) |
|---|---|
| Pharmacologic class | Topical corticosteroids by potency |
| Onset / peak / duration | Symptom relief within days. |
| Half-life / level | Local; minimal systemic absorption when used correctly. |
| High-alert (ISMP) | No |
| Black box warning | None |
| Antidote / reversal | Discontinue; supportive skin care. |
| Pregnancy / lactation | Low-potency use generally acceptable. |
Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.
Topical corticosteroids — Anti-inflammatory (skin); Topical corticosteroids by potency.
Identification
- Therapeutic class: Anti-inflammatory (skin).
- Pharmacologic class: Topical corticosteroids by potency.
Pharmacology
- Mechanism of action: Reduce skin inflammation, itching, and immune response.
- Onset / peak / duration: Symptom relief within days.
- Half-life / therapeutic level: Local; minimal systemic absorption when used correctly.
Clinical use
- Indications: Eczema, dermatitis, psoriasis, inflammatory and pruritic skin conditions.
- Usual dose, route, frequency: Apply a thin layer one to two times daily; potency and duration matched to the area.
- Maximum dose / adjustments: Use the lowest potency that works; limit duration and occlusion; use low potency on the face, groin, and in children.
Safety
- Contraindications: Untreated skin infections, hypersensitivity.
- Black box warning: None.
- Interactions: Minimal topically.
- Pregnancy / lactation: Low-potency use generally acceptable.
- High-alert: No.
Adverse effects
- Common side effects: Burning, dryness, skin thinning with prolonged use.
- Serious effects to report: Skin atrophy, striae, HPA axis suppression (high potency, large areas, occlusion), worsening infection.
- Antidote / reversal: Discontinue; supportive skin care.
Nursing process
- Assessment before administration: Skin condition, area, infection presence.
- Interventions during therapy: Apply thinly; avoid occlusion unless directed; do not use high potency on the face.
- Monitor: Skin response, signs of atrophy or systemic effects.
- Evaluation / expected outcome: Reduced inflammation and itching.
Patient teaching
- Patient teaching: Use a thin layer for the prescribed time; do not cover with airtight dressings unless told; high-potency products are short term.
- Notify provider if: Worsening rash, signs of infection, skin thinning.
- Administration tips: Thin layer; wash hands; match potency to the body area.